Examination of CK2α and NF-κB p65 expression in human benign prostatic hyperplasia and prostate cancer tissues.
about
CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target.CK2 targeted RNAi therapeutic delivered via malignant cell-directed tenfibgen nanocapsule: dose and molecular mechanisms of response in xenograft prostate tumors.CK2 Molecular Targeting-Tumor Cell-Specific Delivery of RNAi in Various Models of Cancer.
P2860
Examination of CK2α and NF-κB p65 expression in human benign prostatic hyperplasia and prostate cancer tissues.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Examination of CK2α and NF-κB ...... a and prostate cancer tissues.
@en
Examination of CK2α and NF-κB ...... a and prostate cancer tissues.
@nl
type
label
Examination of CK2α and NF-κB ...... a and prostate cancer tissues.
@en
Examination of CK2α and NF-κB ...... a and prostate cancer tissues.
@nl
prefLabel
Examination of CK2α and NF-κB ...... a and prostate cancer tissues.
@en
Examination of CK2α and NF-κB ...... a and prostate cancer tissues.
@nl
P2093
P2860
P1476
Examination of CK2α and NF-κB ...... a and prostate cancer tissues.
@en
P2093
Abdul Khaliq Naveed
Badar Murtaza
Fatima Qaiser
Iqbal Muhammad
Rubina Younis
Sarah Sadiq
Shoaib Naiyar Hashmi
Thomas S Rector
P2860
P2888
P356
10.1007/S11010-016-2765-3
P577
2016-07-19T00:00:00Z